Mail

Australia markets open in 8 hours 39 minutes

ALL ORDS
7,384.70
-2.00(-0.03%)
AUD/USD
0.6578
+0.0026(+0.40%)
ASX 200
7,173.30
-5.10(-0.07%)
OIL
70.20
+0.82(+1.18%)
GOLD
2,052.30
+4.40(+0.21%)
Bitcoin AUD
65,808.52
-1,381.31(-2.06%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

0.3400

+0.0160

(+4.94%)

At close: 03:59PM EST

0.3759

+0.03

(+8.96%)

Pre-market:

09:12AM EST

Currency in USD

Valuation measures⁴

Market cap (intra-day)	5.05M
Enterprise value	-3.44M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	0.76
Enterprise value/revenue	N/A
Enterprise value/EBITDA	0.35

Trading information

Stock price history

Beta (5Y monthly)	0.77
52-week change ³	-87.02%
S&P500 52-week change ³	14.78%
52-week high ³	3.8200
52-week low ³	0.2740
50-day moving average ³	0.4283
200-day moving average ³	1.0128

Share statistics

Avg vol (3-month) ³	962.77k
Avg vol (10-day) ³	103.16k
Shares outstanding ⁵	14.87M
Implied shares outstanding ⁶	14.87M
Float ⁸	5.77M
% held by insiders ¹	68.00%
% held by institutions ¹	1.67%
Shares short (14 Nov 2023) ⁴	187.81k
Short ratio (14 Nov 2023) ⁴	0.07
Short % of float (14 Nov 2023) ⁴	2.93%
Short % of shares outstanding (14 Nov 2023) ⁴	1.26%
Shares short (prior month 12 Oct 2023) ⁴	46.05k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2022
Most-recent quarter (mrq)	29 Sept 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-53.33%
Return on equity (ttm)	-99.20%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	N/A
Net income avi to common (ttm)	-9.48M
Diluted EPS (ttm)	-0.7200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	8.49M
Total cash per share (mrq)	0.57
Total debt (mrq)	N/A
Total debt/equity (mrq)	N/A
Current ratio (mrq)	4.32
Book value per share (mrq)	0.47

Cash flow statement

Operating cash flow (ttm)	-7.61M
Levered free cash flow (ttm)	-4.28M